Inhibition of Akt potentiates 2-DG - Induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia

Joanna DeSalvo, Jeffim N. Kuznetsov, Jianfeng Du, Gilles M. Leclerc, Guy J. Leclerc, Theodore Lampidis, Julio Barredo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The ability to pair the regulation of metabolism and cellular energetics with oncogenes and tumor suppressor genes provides cancer cells with a growth and survival advantage over normal cells. We investigated the mechanism of cell death induced by 2-deoxy-D-glucose (2-DG), a sugar analog with dual activity of inhibiting glycolysis and Nlinked glycosylation, in acute lymphoblastic leukemia (ALL). We found that, unlike most other cancer phenotypes in which 2-DG only inhibits cell proliferation under normoxic conditions, ALL lymphoblasts undergo apoptosis. Bp-ALL cell lines and primary cells exhibited sensitivity to 2-DG, whereas T-ALL cells were relatively resistant, revealing phenotypic differences within ALL subtypes. Cotreatment with D-mannose, a sugar essential for N-linked glycosylation, rescues 2-DG - treated ALL cells, indicating that inhibition of N-linked glycosylation and induction of ER stress and the unfolded protein response (UPR) is the predominant mechanism of 2-DG's cytotoxicity in ALL. 2-DG-treated ALL cells exhibit upregulation of P-AMPK, P-Akt, and induction of ER stress/UPR markers (IRE1a, GRP78, P-eIF2α, and CHOP), which correlate with PARP cleavage and apoptosis. In addition, we find that pharmacologic and genetic Akt inhibition upregulates P-AMPK, downregulates UPR, and sensitizes ALL cells to remarkably low doses of 2-DG (0.5 mmol/L), inducing 85% cell death and overcoming the relative resistance of T-ALL. In contrast, AMPK knockdown rescues ALL cells by upregulating the prosurvival UPR signaling. Therefore, 2-DG induces ALL cell death under normoxia by inducing ER stress, andAKTand AMPK, traditionally thought to operate predominantly on the glycolytic pathway, differentially regulate UPR activity to determine cell death or survival.

Original languageEnglish
Pages (from-to)969-978
Number of pages10
JournalMolecular Cancer Research
Volume10
Issue number7
DOIs
StatePublished - Jul 1 2012

Fingerprint

Unfolded Protein Response
Deoxyglucose
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Down-Regulation
Apoptosis
AMP-Activated Protein Kinases
Cell Death
Glycosylation
Heat-Shock Proteins
Up-Regulation
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Glycolysis
Mannose
Tumor Suppressor Genes
Oncogenes
Neoplasms
Cell Survival
Cell Proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Inhibition of Akt potentiates 2-DG - Induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. / DeSalvo, Joanna; Kuznetsov, Jeffim N.; Du, Jianfeng; Leclerc, Gilles M.; Leclerc, Guy J.; Lampidis, Theodore; Barredo, Julio.

In: Molecular Cancer Research, Vol. 10, No. 7, 01.07.2012, p. 969-978.

Research output: Contribution to journalArticle

DeSalvo, Joanna ; Kuznetsov, Jeffim N. ; Du, Jianfeng ; Leclerc, Gilles M. ; Leclerc, Guy J. ; Lampidis, Theodore ; Barredo, Julio. / Inhibition of Akt potentiates 2-DG - Induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. In: Molecular Cancer Research. 2012 ; Vol. 10, No. 7. pp. 969-978.
@article{d6f9da5c5e81468f8a870af6285b4598,
title = "Inhibition of Akt potentiates 2-DG - Induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia",
abstract = "The ability to pair the regulation of metabolism and cellular energetics with oncogenes and tumor suppressor genes provides cancer cells with a growth and survival advantage over normal cells. We investigated the mechanism of cell death induced by 2-deoxy-D-glucose (2-DG), a sugar analog with dual activity of inhibiting glycolysis and Nlinked glycosylation, in acute lymphoblastic leukemia (ALL). We found that, unlike most other cancer phenotypes in which 2-DG only inhibits cell proliferation under normoxic conditions, ALL lymphoblasts undergo apoptosis. Bp-ALL cell lines and primary cells exhibited sensitivity to 2-DG, whereas T-ALL cells were relatively resistant, revealing phenotypic differences within ALL subtypes. Cotreatment with D-mannose, a sugar essential for N-linked glycosylation, rescues 2-DG - treated ALL cells, indicating that inhibition of N-linked glycosylation and induction of ER stress and the unfolded protein response (UPR) is the predominant mechanism of 2-DG's cytotoxicity in ALL. 2-DG-treated ALL cells exhibit upregulation of P-AMPK, P-Akt, and induction of ER stress/UPR markers (IRE1a, GRP78, P-eIF2α, and CHOP), which correlate with PARP cleavage and apoptosis. In addition, we find that pharmacologic and genetic Akt inhibition upregulates P-AMPK, downregulates UPR, and sensitizes ALL cells to remarkably low doses of 2-DG (0.5 mmol/L), inducing 85{\%} cell death and overcoming the relative resistance of T-ALL. In contrast, AMPK knockdown rescues ALL cells by upregulating the prosurvival UPR signaling. Therefore, 2-DG induces ALL cell death under normoxia by inducing ER stress, andAKTand AMPK, traditionally thought to operate predominantly on the glycolytic pathway, differentially regulate UPR activity to determine cell death or survival.",
author = "Joanna DeSalvo and Kuznetsov, {Jeffim N.} and Jianfeng Du and Leclerc, {Gilles M.} and Leclerc, {Guy J.} and Theodore Lampidis and Julio Barredo",
year = "2012",
month = "7",
day = "1",
doi = "10.1158/1541-7786.MCR-12-0125",
language = "English",
volume = "10",
pages = "969--978",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Inhibition of Akt potentiates 2-DG - Induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia

AU - DeSalvo, Joanna

AU - Kuznetsov, Jeffim N.

AU - Du, Jianfeng

AU - Leclerc, Gilles M.

AU - Leclerc, Guy J.

AU - Lampidis, Theodore

AU - Barredo, Julio

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The ability to pair the regulation of metabolism and cellular energetics with oncogenes and tumor suppressor genes provides cancer cells with a growth and survival advantage over normal cells. We investigated the mechanism of cell death induced by 2-deoxy-D-glucose (2-DG), a sugar analog with dual activity of inhibiting glycolysis and Nlinked glycosylation, in acute lymphoblastic leukemia (ALL). We found that, unlike most other cancer phenotypes in which 2-DG only inhibits cell proliferation under normoxic conditions, ALL lymphoblasts undergo apoptosis. Bp-ALL cell lines and primary cells exhibited sensitivity to 2-DG, whereas T-ALL cells were relatively resistant, revealing phenotypic differences within ALL subtypes. Cotreatment with D-mannose, a sugar essential for N-linked glycosylation, rescues 2-DG - treated ALL cells, indicating that inhibition of N-linked glycosylation and induction of ER stress and the unfolded protein response (UPR) is the predominant mechanism of 2-DG's cytotoxicity in ALL. 2-DG-treated ALL cells exhibit upregulation of P-AMPK, P-Akt, and induction of ER stress/UPR markers (IRE1a, GRP78, P-eIF2α, and CHOP), which correlate with PARP cleavage and apoptosis. In addition, we find that pharmacologic and genetic Akt inhibition upregulates P-AMPK, downregulates UPR, and sensitizes ALL cells to remarkably low doses of 2-DG (0.5 mmol/L), inducing 85% cell death and overcoming the relative resistance of T-ALL. In contrast, AMPK knockdown rescues ALL cells by upregulating the prosurvival UPR signaling. Therefore, 2-DG induces ALL cell death under normoxia by inducing ER stress, andAKTand AMPK, traditionally thought to operate predominantly on the glycolytic pathway, differentially regulate UPR activity to determine cell death or survival.

AB - The ability to pair the regulation of metabolism and cellular energetics with oncogenes and tumor suppressor genes provides cancer cells with a growth and survival advantage over normal cells. We investigated the mechanism of cell death induced by 2-deoxy-D-glucose (2-DG), a sugar analog with dual activity of inhibiting glycolysis and Nlinked glycosylation, in acute lymphoblastic leukemia (ALL). We found that, unlike most other cancer phenotypes in which 2-DG only inhibits cell proliferation under normoxic conditions, ALL lymphoblasts undergo apoptosis. Bp-ALL cell lines and primary cells exhibited sensitivity to 2-DG, whereas T-ALL cells were relatively resistant, revealing phenotypic differences within ALL subtypes. Cotreatment with D-mannose, a sugar essential for N-linked glycosylation, rescues 2-DG - treated ALL cells, indicating that inhibition of N-linked glycosylation and induction of ER stress and the unfolded protein response (UPR) is the predominant mechanism of 2-DG's cytotoxicity in ALL. 2-DG-treated ALL cells exhibit upregulation of P-AMPK, P-Akt, and induction of ER stress/UPR markers (IRE1a, GRP78, P-eIF2α, and CHOP), which correlate with PARP cleavage and apoptosis. In addition, we find that pharmacologic and genetic Akt inhibition upregulates P-AMPK, downregulates UPR, and sensitizes ALL cells to remarkably low doses of 2-DG (0.5 mmol/L), inducing 85% cell death and overcoming the relative resistance of T-ALL. In contrast, AMPK knockdown rescues ALL cells by upregulating the prosurvival UPR signaling. Therefore, 2-DG induces ALL cell death under normoxia by inducing ER stress, andAKTand AMPK, traditionally thought to operate predominantly on the glycolytic pathway, differentially regulate UPR activity to determine cell death or survival.

UR - http://www.scopus.com/inward/record.url?scp=84864025896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864025896&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-12-0125

DO - 10.1158/1541-7786.MCR-12-0125

M3 - Article

C2 - 22692960

AN - SCOPUS:84864025896

VL - 10

SP - 969

EP - 978

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 7

ER -